Detalhe da pesquisa
1.
Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
J Urol
; 211(3): 426-435, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085711
2.
Postchemotherapy Residual Tumor Resection in Patients with Elevated Tumor Markers.
J Urol
; 207(3): 617-626, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694152
3.
Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND).
World J Urol
; 40(2): 349-354, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731264
4.
Late relapsing germ cell tumors with elevated tumor markers.
World J Urol
; 40(2): 363-371, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518930
5.
Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.
World J Urol
; 40(6): 1505-1512, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279732
6.
Short-term and long-term outcomes after resection of thoracic growing teratoma syndrome.
World J Urol
; 39(7): 2579-2585, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33128597
7.
Robotic Assisted Retroperitoneal Lymph Node Dissection for Small Volume Metastatic Testicular Cancer.
J Urol
; 204(6): 1242-1248, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717162
8.
Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of 68Ga-PSMA and 11C-Choline in a Large, Multi-Institutional Series of Extended Salvage Lymph Node Dissections.
J Urol
; 204(2): 296-302, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068488
10.
Oncological outcome of patients treated with spot-specific salvage lymphnode dissection (sLND) for positron-emission tomography (PET)-positive prostate cancer (PCa) relapse.
World J Urol
; 37(10): 2081-2090, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30643974
11.
Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy-Are 2 Biopsy Cores per Magnetic Resonance Imaging Lesion Required?
J Urol
; 200(5): 1030-1034, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29733837
12.
Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate.
J Urol
; 199(3): 691-698, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28941924
13.
Comparison of patient comfort between MR-guided in-bore and MRI/ultrasound fusion-guided prostate biopsies within a prospective randomized trial.
World J Urol
; 34(2): 215-20, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26055645
16.
Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
J Urol
; 192(5): 1374-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24866597
17.
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.
Eur Radiol
; 24(10): 2582-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24972954
18.
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Clin Cancer Res
; 30(2): 404-412, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967143
19.
Phase 2 Single-arm Trial of Primary Retroperitoneal Lymph Node Dissection in Patients with Seminomatous Testicular Germ Cell Tumors with Clinical Stage IIA/B (PRIMETEST).
Eur Urol
; 84(1): 25-31, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372627
20.
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
BJUI Compass
; 4(1): 123-129, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36569505